Calithera Biosciences Inc (CALA.OQ)
CALA.OQ on NASDAQ Stock Exchange Global Select Market
4.60USD
21 Aug 2018
4.60USD
21 Aug 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$4.60
$4.60
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
57,820
57,820
52-wk High
$18.30
$18.30
52-wk Low
$4.07
$4.07
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 17.07 | -0.086 |
| Mar '18 | 5.19 | -0.369 | |
| FY 2017 | Dec '17 | 7.25 | -0.308 |
| Sep '17 | 7.25 | -0.171 | |
| Jun '17 | 7.26 | -0.147 | |
| Mar '17 | 4.19 | -0.221 | |
| FY 2016 | Dec '16 | 0.00 | -0.452 |
| Sep '16 | 0.00 | -0.438 | |
| Jun '16 | 0.00 | -0.546 | |
| Mar '16 | 0.00 | -0.521 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 4 | 4.85 | 7.30 | 0.00 | 6.90 |
| Quarter Ending Dec-18 | 4 | 4.85 | 7.30 | 0.00 | 6.90 |
| Year Ending Dec-18 | 4 | 31.96 | 36.90 | 22.25 | 23.20 |
| Year Ending Dec-19 | 4 | 22.23 | 36.90 | 0.00 | 16.80 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 5 | -0.40 | -0.21 | -0.58 | -0.11 |
| Quarter Ending Dec-18 | 5 | -0.41 | -0.21 | -0.59 | -0.11 |
| Year Ending Dec-18 | 5 | -1.26 | -0.87 | -1.62 | -1.07 |
| Year Ending Dec-19 | 5 | -1.90 | -1.00 | -2.75 | -2.58 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 85.69 | 32.76 | |
| P/E High - Last 5 Yrs. | -- | 300.66 | 45.44 | |
| P/E Low - Last 5 Yrs. | -- | 92.08 | 24.26 | |
| Beta | -- | 0.93 | 0.89 | |
| Price to Sales (TTM) | 53.46 | 114.99 | 5.75 | |
| Price to Book (MRQ) | 3.76 | 15.52 | 5.00 | |
| Price to Tangible Book (MRQ) | 3.77 | 14.52 | 6.57 | |
| Price to Cash Flow (TTM) | -- | 72.88 | 23.29 | |
| % Owned Institutions | 90.00 | 14.70 | 2.21 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.36 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.26 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 1.72 | 5.22 | |
| Payout Ratio(TTM) | -- | 16.50 | 43.78 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 411.56 | 8.01 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 80.51 | 5.64 | |
| Sales - 5 Yr. Growth Rate | -- | 32.27 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 73.06 | 29.15 | 20.60 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 37.17 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 39.85 | 10.66 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 40.43 | 15.34 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.91 | 2.22 |
| Current Ratio (MRQ) | 4.95 | 5.46 | 3.03 |
| LT Debt to Equity (MRQ) | 0.00 | 35.26 | 12.51 |
| Total Debt to Equity (MRQ) | 0.00 | 37.08 | 16.85 |
| Interest Coverage (TTM) | -- | -102.36 | 32.63 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 39.17 | 54.37 | |
| Gross Margin - 5 Yr. Avg. | -- | 50.57 | 52.17 | |
| EBITD Margin (TTM) | -256.99 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -600.69 | 10.68 | |
| Operating Margin (TTM) | -259.69 | -759.79 | 4.32 | |
| Operating Margin - 5 Yr. Avg. | -- | -621.72 | 6.11 | |
| Pre-Tax Margin (TTM) | -251.99 | -733.64 | 5.18 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -627.42 | 6.51 | |
| Net Profit Margin (TTM) | -251.99 | -735.01 | 1.48 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -630.47 | 2.78 | |
| Effective Tax Rate (TTM) | -- | 23.33 | 23.11 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.66 | 23.97 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 228,940 | 23,231,105 | 860,375,625 | |
| Net Income/Employee (TTM) | -576,900 | 3,144,294 | 101,207,245 | |
| Receivable Turnover (TTM) | -- | 20.89 | 5.87 | |
| Inventory Turnover (TTM) | -- | 2.46 | 3.41 | |
| Asset Turnover (TTM) | 0.08 | 0.41 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -20.80 | -0.16 | 11.13 | |
| Return on Assets - 5 Yr. Avg. | -- | 3.51 | 12.40 | |
| Return on Investment (TTM) | -24.22 | 1.78 | 14.61 | |
| Return on Investment - 5 Yr. Avg. | -- | 2.56 | 16.13 | |
| Return on Equity (TTM) | -26.14 | 3.28 | 16.33 | |
| Return on Equity - 5 Yr. Avg. | -- | 3.42 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -7.81 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Calithera Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 6.15 | 2.49 | 62 | 53 |
| 13 Week | -3.63 | -8.32 | 44 | 66 |
| 26 Week | 53.33 | 41.68 | 85 | 80 |
| 52 Week | 429.14 | 348.49 | 98 | 50 |
| YTD | 430.77 | 366.12 | 99 | 61 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 68.24% |
| # of Holders: | 129 |
| Total Shares Held: | 24,559,239 |
| 3 Mo. Net Change: | -2,869,268 |
| # New Positions: | 17 |
| # Closed Positions: | 31 |
| # Increased Positions: | 51 |
| # Reduced Positions: | 74 |
| # Net Buyers: | -23 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.